Health
Who benefits from the panic around the new type of Corona virus? The situation is under control, and there is now cause for worrying. In the early 2000s, around 100 billion USD was spent to “contain the spread” of the SARS-Co virus. In 18 years, around 700 people have died from it – just as many who dies from a usual influenza. In this case, the big pharmaceutical companies could profit largely. Why this panic? The answer is the classical: “who benefits from it?”
Do big pharmaceutical companies profit from the panic around the new type of Corona virus?
Falseaccording to EUvsDisinfo
EUvsDisinfo checked this claim on 27 January 2020.
“disinformation”
Around this claim
- First seen
- 27 January 2020, tsargrad.tv, according to EUvsDisinfo (EEAS East StratCom Task Force)
Where it turned up
- Seen at tsargrad.tv, according to EUvsDisinfo (EEAS East StratCom Task Force), 27 January 2020
Related
More in Health
See all 16,580 fact-checks- Misleadingaccording to FactCheck.org20 November 2026The Moderna mRNA flu vaccine “didn’t work” and came with “massive side effects.”HealthUnited States
- Checkedby Factcrescendo Sri Lanka20 November 2026That the price of a bottle of arrack (750 ml extra special arrack) has been reduced by 530 rupees, and that alcohol prices went down with the 2027 budgetMachine-translated from Sinhala. Original: ගල් අරක්කු (මිලි ලීටර් 750 අති විශේෂ අරක්කු) බෝතලයක මිල රුපියල් 530කින් අඩු කර ඇති බවත්, 2027 අයවැයෙන් මත්පැන් මිල පහළ ගිය බවත්Economy and moneySri Lanka
- Checkedby فکتنامه19 November 2026Can iron deficiency and anemia be diagnosed from a person's face?Machine-translated from Persian. Original: آیا میتوان کمبود آهن و کمخونی را از روی چهره تشخیص داد؟Health
Something wrong here? Report it by emailinfo@factiz.org
The verdict belongs to the newsroom: report an error in it to them, through their article above. Report an error in what Factiz added, such as the translation, the theme or the names, to us.
Record from: EUvsDisinfo, European External Action Service. Licence: EEAS legal notice: reuse is authorised, provided the source is acknowledged; snapshot: Mendeley Data yhdtkszvgp v3, CC BY 4.0.
The sources are the verdict.